• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2008年至2011年转诊至伊朗德黑兰皮肤病与麻风病研究培训中心的疑似皮肤利什曼病患者情况。

Cutaneous leishmaniasis in suspected patients referred to the center for research and training in skin diseases and leprosy, tehran, iran from 2008 to 2011.

作者信息

Mohammadi Akram Mir Amin, Khamesipour Ali, Khatami Alireza, Javadi Amir, Nassiri-Kashani Mansour, Firooz Alireza, Dowlati Yahya, Behnia Massoud, Eskandari Seyyed Ebrahim

机构信息

Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran.

Department of Community Medicine, School of Medicine, Qazvin University, Qazvin, Iran.

出版信息

Iran J Parasitol. 2013 Jul;8(3):430-6.

PMID:24454437
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3887245/
Abstract

BACKGROUND

Cutaneous leishmaniasis (CL) is a major health problem in many parts of Iran, although diagnosis of CL especially in the endemic area is easy, but treatment and management of the disease is a global dilemma. Diagnosis of CL in non-endemic area is not as simple as in endemic foci. In this study, the status and the proportions of CL induced by Leishmania major and L. tropica among CL suspected patients referred to the Center for Research and Training in Skin Diseases and Leprosy, (CRTSDL) during 2008 to 2011 are described.

METHODS

CL patients with suspected lesions were clinically examined. History of trip to zoonotic CL and/or anthroponotic CL endemic areas and the characteristics of their lesion(s) were recorded. Diagnosis of the lesion was done using direct smear microscopy, culture and conventional polymerase chain reaction (PCR).

RESULTS

A total of 404 (M = 256, F = 148) patients with 776 lesions were recruited and parasitologically examined. The results showed that 255 of the patients with 613 lesions; patients with lesion(s) induced by L. major=147 (M = 63, 43%, F = 84, 57%) and lesion(s) induced by L. tropica=108 (M = 35, 32%, F = 73, 68%). History of travel to endemic area was not always correlated with isolated Leishmania species.

CONCLUSION

Although travel history to endemic area is an important factor to be considered for diagnosis, but parasitological confirmation is necessary initiation of treatment.

摘要

背景

皮肤利什曼病(CL)是伊朗许多地区的一个主要健康问题,尽管CL的诊断在流行地区尤其是容易的,但该疾病的治疗和管理是一个全球性难题。非流行地区CL的诊断不像在流行病灶中那么简单。在本研究中,描述了2008年至2011年期间转诊至皮肤病和麻风病研究与培训中心(CRTSDL)的疑似CL患者中由硕大利什曼原虫和热带利什曼原虫引起的CL的状况和比例。

方法

对有疑似病变的CL患者进行临床检查。记录前往动物源性CL和/或人源性CL流行地区的旅行史及其病变特征。使用直接涂片显微镜检查、培养和常规聚合酶链反应(PCR)进行病变诊断。

结果

共招募了404名(男性 = 256名,女性 = 148名)有776处病变的患者并进行了寄生虫学检查。结果显示,255名患者有613处病变;由硕大利什曼原虫引起病变的患者 = 147名(男性 = 63名,43%,女性 = 84名,57%),由热带利什曼原虫引起病变的患者 = 108名(男性 = 35名,32%,女性 = 73名,68%)。前往流行地区的旅行史并不总是与分离出的利什曼原虫种类相关。

结论

尽管前往流行地区的旅行史是诊断时要考虑的一个重要因素,但寄生虫学确诊是开始治疗的必要条件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bde/3887245/e5da5ce0a8da/IJPA-8-430-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bde/3887245/e5da5ce0a8da/IJPA-8-430-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7bde/3887245/e5da5ce0a8da/IJPA-8-430-g001.jpg

相似文献

1
Cutaneous leishmaniasis in suspected patients referred to the center for research and training in skin diseases and leprosy, tehran, iran from 2008 to 2011.2008年至2011年转诊至伊朗德黑兰皮肤病与麻风病研究培训中心的疑似皮肤利什曼病患者情况。
Iran J Parasitol. 2013 Jul;8(3):430-6.
2
An overview of a diagnostic and epidemiologic reappraisal of cutaneous leishmaniasis in Iran.伊朗皮肤利什曼病的诊断和流行病学再评估概述。
Braz J Infect Dis. 2011 Jan-Feb;15(1):17-21.
3
[Comparison of polymerase chain reaction using kinetoplast DNA specific primers and other parasitological methods in the diagnosis of clinical samples of suspected patients with cutaneous leishmaniasis in Şanlıurfa].[在Şanlıurfa疑似皮肤利什曼病患者临床样本诊断中使用动基体DNA特异性引物的聚合酶链反应与其他寄生虫学方法的比较]
Mikrobiyol Bul. 2017 Oct;51(4):340-349. doi: 10.5578/mb.61840.
4
Identification of Leishmania species by kinetoplast DNA-polymerase chain reaction for the first time in Khaf district, Khorasan-e-Razavi province, Iran.首次在伊朗呼罗珊拉扎维省哈夫地区通过动基体DNA聚合酶链反应鉴定利什曼原虫种类。
Trop Parasitol. 2015 Jan-Jun;5(1):50-4. doi: 10.4103/2229-5070.145587.
5
New epidemiological pattern of cutaneous leishmaniasis in two pre-Saharan arid provinces, southern Morocco.摩洛哥南部撒哈拉沙漠前两个干旱省份皮肤利什曼病的新流行模式。
Acta Trop. 2017 Sep;173:11-16. doi: 10.1016/j.actatropica.2017.05.016. Epub 2017 May 17.
6
Molecular identification of Leishmania isolates obtained from patients suspected as having cutaneous leishmaniasis referred to reference laboratories from Yazd province in central Iran.从伊朗中部亚兹德省转诊至参考实验室的疑似皮肤利什曼病患者中分离出的利什曼原虫的分子鉴定。
Adv Biomed Res. 2013 Nov 30;2:92. doi: 10.4103/2277-9175.122525. eCollection 2013.
7
A newly emerged cutaneous leishmaniasis focus in central Iran.伊朗中部新出现的皮肤利什曼病集中区。
Int J Infect Dis. 2013 Dec;17(12):e1198-206. doi: 10.1016/j.ijid.2013.07.003. Epub 2013 Sep 6.
8
Molecular Identification of Cutaneous Leishmaniasis Species in the Northcentral Iranian Province of Alborz: Is There a New Focus on Cutaneous Leishmaniasis in the Province?伊朗中北部阿尔伯兹省皮肤利什曼病种类的分子鉴定:该省是否存在皮肤利什曼病新疫源地?
Iran J Parasitol. 2023 Apr-Jun;18(2):244-250. doi: 10.18502/ijpa.v18i2.13191.
9
Possible introduction of to urban areas determined by epidemiological and clinical profiles of patients with cutaneous leishmaniasis in Casablanca (Morocco).根据卡萨布兰卡(摩洛哥)皮肤利什曼病患者的流行病学和临床特征确定向城市地区引入(相关内容)的可能性。
Parasite Epidemiol Control. 2020 Jan 3;9:e00129. doi: 10.1016/j.parepi.2019.e00129. eCollection 2020 May.
10
Cutaneous and post kala-azar dermal leishmaniasis caused by Leishmania infantum in endemic areas of visceral leishmaniasis, northwestern Iran 2002-2011: a case series.2002-2011 年伊朗西北部内脏利什曼病流行区感染利什曼原虫引起的皮肤和黑热病后皮肤利什曼病:病例系列。
Pathog Glob Health. 2013 Jun;107(4):194-7. doi: 10.1179/2047773213Y.0000000097.

引用本文的文献

1
Diagnosis of Human Cutaneous Leishmaniasis: A Comparative Study Using CL Detect Dipstick, Direct Smear and Polymerase Chain Reaction Methods.人皮肤利什曼病的诊断:CL 检测棒、直接涂片和聚合酶链反应方法的比较研究。
Acta Parasitol. 2023 Jun;68(2):328-333. doi: 10.1007/s11686-023-00662-5. Epub 2023 Mar 13.
2
Non-Endemic Leishmaniases Reported Globally in Humans between 2000 and 2021-A Comprehensive Review.2000年至2021年全球报告的人间非地方性利什曼病——一项全面综述
Pathogens. 2022 Aug 16;11(8):921. doi: 10.3390/pathogens11080921.
3
The Geographical Distribution of Human Cutaneous and Visceral Species Identified by Molecular Methods in Iran: A Systematic Review With Meta-Analysis.

本文引用的文献

1
Case study for a vaccine against leishmaniasis.利什曼病疫苗的病例研究。
Vaccine. 2013 Apr 18;31 Suppl 2:B244-9. doi: 10.1016/j.vaccine.2012.11.080.
2
Spatial distribution and molecular identification of leishmania species from endemic foci of South-eastern iran.伊朗东南部地方病疫源地利什曼原虫物种的空间分布与分子鉴定
Iran J Parasitol. 2012;7(1):45-52.
3
Cutaneous leishmaniasis in bam: a comparative evaluation of pre- and post-earthquake years (1999-2008).巴姆地区的皮肤利什曼病:地震前后年份(1999 - 2008年)的比较评估
伊朗应用分子方法鉴定的人类皮肤和内脏物种的地理分布:系统评价和荟萃分析。
Front Public Health. 2021 Jun 25;9:661674. doi: 10.3389/fpubh.2021.661674. eCollection 2021.
4
High resolution melting assay in discrimination of the main etiologic agents of leishmaniasis in Iran.高分辨率熔解曲线分析在鉴别伊朗利什曼病主要病原体中的应用
Iran J Microbiol. 2021 Feb;13(1):137-144. doi: 10.18502/ijm.v13i1.5505.
5
Immune response in cutaneous leishmaniasis patients with healing . non-healing lesions.皮肤利什曼病患者愈合及未愈合皮损的免疫反应
Iran J Microbiol. 2020 Jun;12(3):249-255.
6
Cutaneous Leishmaniasis Situation and Predicting the Distribution of Phlebotomus papatasi and P. sergenti as Vectors of Leishmaniasis in Ardabil Province, Iran.伊朗阿尔达比勒省皮肤利什曼病现状及预测作为利什曼病传播媒介的巴氏白蛉和塞尔吉白蛉的分布情况
Korean J Parasitol. 2020 Jun;58(3):229-236. doi: 10.3347/kjp.2020.58.3.229. Epub 2020 Jun 26.
7
Safety Evaluation of Topical Application of Nano-Liposomal Form of Amphotericin B (SinaAmpholeish) on Healthy Volunteers: Phase I Clinical Trial.两性霉素B纳米脂质体剂型(SinaAmpholeish)局部应用于健康志愿者的安全性评估:I期临床试验
Iran J Parasitol. 2019 Apr-Jun;14(2):197-203.
8
Lived Experiences of Patients Suffering from Acute Old World Cutaneous Leishmaniasis: A Qualitative Content Analysis Study from Iran.急性旧世界皮肤利什曼病患者的生活经历:一项来自伊朗的定性内容分析研究
J Arthropod Borne Dis. 2018 Jun 13;12(2):180-195. eCollection 2018 Jun.
9
Identification of etiologic agents of cutaneous Leishmaniasis in palpebral position followed by effective therapy.睑部皮肤利什曼病病原体的鉴定及后续有效治疗。
J Educ Health Promot. 2017 Jun 5;6:44. doi: 10.4103/jehp.jehp_118_14. eCollection 2017.
Iran J Public Health. 2011;40(2):49-56. Epub 2011 Jun 30.
4
Leishmaniasis worldwide and global estimates of its incidence.全球利什曼病及其发病率的全球估计。
PLoS One. 2012;7(5):e35671. doi: 10.1371/journal.pone.0035671. Epub 2012 May 31.
5
Vaccines for the leishmaniases: proposals for a research agenda.利什曼病疫苗:研究议程提案
PLoS Negl Trop Dis. 2011 Mar 29;5(3):e943. doi: 10.1371/journal.pntd.0000943.
6
Emergence of a new focus of anthroponotic cutaneous leishmaniasis due to Leishmania tropica in rural communities of Bam district after the earthquake, Iran.伊朗 Bam 地区地震后,由于热带利什曼原虫,农村社区中出现了新的人体皮肤利什曼病焦点。
Trop Med Int Health. 2011 Apr;16(4):510-3. doi: 10.1111/j.1365-3156.2011.02729.x. Epub 2011 Jan 24.
7
Leishmaniasis in the World Health Organization Eastern Mediterranean Region.世界卫生组织东地中海区域的利什曼病。
Int J Antimicrob Agents. 2010 Nov;36 Suppl 1:S62-5. doi: 10.1016/j.ijantimicag.2010.06.023. Epub 2010 Aug 21.
8
Leishmania species: detection and identification by nested PCR assay from skin samples of rodent reservoirs.利什曼原虫种属:通过巢式 PCR 检测方法从啮齿动物储存宿主的皮肤样本中进行检测和鉴定。
Exp Parasitol. 2010 Dec;126(4):552-6. doi: 10.1016/j.exppara.2010.06.003. Epub 2010 Jun 8.
9
Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis.灭活全寄生虫疫苗在预防利什曼病中的疗效:一项荟萃分析。
Vaccine. 2009 Jul 30;27(35):4747-53. doi: 10.1016/j.vaccine.2009.05.084. Epub 2009 Jun 18.
10
First generation leishmaniasis vaccines: a review of field efficacy trials.第一代利什曼病疫苗:现场效力试验综述
Vaccine. 2008 Dec 9;26(52):6759-67. doi: 10.1016/j.vaccine.2008.09.085. Epub 2008 Oct 23.